MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM FDA approval date
The FDA approved MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM on 22 Dec 2025.
- FDA approval date
- 22 Dec 2025
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2025-12-22Day | MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA217338", "applicant_as_listed_by_fda": "RECKITT BENCKISER", "brand_names": ["MUCINEX 12HR COLD & FEVER MULTI-SYMPTOM"], "active_ingredients": ["DEXTROMETHORPHAN HYDROBROMIDE", "GUAIFENESIN", "NAPROXEN SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251222", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |